Chamomile shown beneficial for generalized anxiety disorder

Journal of Clinical PsychopharmacologyGood old chamomile. In this randomized, double-blind, placebo-controlled efficacy study published in the Journal of Clinical Psychopharmacology that evaluated chamomile for the treatment of Generalized Anxiety Disorder (GAD), the investigators report a "significantly greater reduction in mean total HAM-A score during chamomile versus placebo therapy." (HAM-A = Hamilton Anxiety Rating) They also noted improvement in secondary outcomes including the Beck Anxiety Inventory, Psychological Well Being, and Clinical Global Impression Severity scores. Their conclusion: "This is the first controlled clinical trial of chamomile extract for GAD. The results suggest that chamomile may have modest anxiolytic activity in patients with mild to moderate GAD."

Previous
Previous

Internet-based therapy for insomnia: studies show success

Next
Next

How well can you smell: autoimmunity & neuropsychiatric disorders